Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

486 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Individual HLAs affect survival after allogeneic stem cell transplantation in adult T-cell leukaemia/lymphoma.
Morishima S, Yoshimitsu M, Shindo T, Utsunomiya A, Ishida T, Ito A, Nakano N, Kawakita T, Eto T, Suehiro Y, Itonaga H, Mori Y, Miyazaki Y, Kanda J, Uchida N, Sawayama Y, Tomori S, Ichinohe T, Atsuta Y, Fukuda T, Kato K; ATL Working Group of the Japanese Society for Transplantation and Cellular Therapy. Morishima S, et al. Among authors: kawakita t. HLA. 2024 Jun;103(6):e15555. doi: 10.1111/tan.15555. HLA. 2024. PMID: 38887872
Increased non-relapse mortality due to high-dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukaemia in adults.
Arai Y, Kondo T, Shigematsu A, Tanaka J, Ohashi K, Fukuda T, Kawakita T, Mori T, Hoshino T, Onizuka M, Ozawa Y, Yoshida S, Ueda Y, Mizuno I, Atsuta Y, Mizuta S; Japan Society for Haematopoietic Cell Transplantation. Arai Y, et al. Among authors: kawakita t. Br J Haematol. 2017 Jul;178(1):106-111. doi: 10.1111/bjh.14652. Epub 2017 Apr 25. Br J Haematol. 2017. PMID: 28439877 Free article.
Outcomes after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia harboring t(7;11)(p15;p15).
Harada K, Doki N, Aoki J, Mori J, Machida S, Masuko M, Uchida N, Najima Y, Fukuda T, Kanamori H, Ogawa H, Ota S, Ogawa K, Takahashi S, Kasai M, Maeda A, Nagafuji K, Kawakita T, Ichinohe T, Atsuta Y. Harada K, et al. Among authors: kawakita t. Haematologica. 2018 Feb;103(2):e69-e72. doi: 10.3324/haematol.2017.179804. Epub 2017 Nov 16. Haematologica. 2018. PMID: 29146707 Free PMC article. No abstract available.
Safety and Efficacy of Once-Daily Intravenous Busulfan in Allogeneic Transplantation: A Matched-Pair Analysis.
Kako S, Fujiwara S, Sato M, Kimura SI, Nakasone H, Ohashi K, Kawakita T, Maeda T, Morishita T, Suzuki R, Fukuda T, Ichinohe T, Kurata M, Atsuta Y, Kanda Y. Kako S, et al. Among authors: kawakita t. Biol Blood Marrow Transplant. 2018 Oct;24(10):2139-2144. doi: 10.1016/j.bbmt.2018.04.015. Epub 2018 Apr 19. Biol Blood Marrow Transplant. 2018. PMID: 29680515 Free article. Clinical Trial.
Clinical course of autologous recovery with chromosomal abnormalities after allogeneic hematopoietic stem cell transplantation.
Kato M, Nakasone H, Nakano N, Fuji S, Shinohara A, Yokoyama H, Sakashita K, Hori T, Takahashi S, Nara M, Kanda Y, Mori T, Takita J, Kawaguchi H, Kawakita T, Ichinohe T, Fukuda T, Atsuta Y, Ogata M; Transplantation Complication Working Group of the Japan Society for Hematopoietic Cell Transplantation. Kato M, et al. Among authors: kawakita t. Bone Marrow Transplant. 2020 Jun;55(6):1023-1028. doi: 10.1038/s41409-019-0765-0. Epub 2019 Dec 9. Bone Marrow Transplant. 2020. PMID: 31819152
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for ATL with HTLV-1 Antibody-Positive Donors.
Yoshimitsu M, Fuji S, Utsunomiya A, Nakano N, Ito A, Ito Y, Miyamoto T, Suehiro Y, Kawakita T, Moriuchi Y, Nakamae H, Kanda Y, Ichinohe T, Fukuda T, Atsuta Y, Kato K; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation. Yoshimitsu M, et al. Among authors: kawakita t. Biol Blood Marrow Transplant. 2020 Apr;26(4):718-722. doi: 10.1016/j.bbmt.2019.12.004. Epub 2019 Dec 9. Biol Blood Marrow Transplant. 2020. PMID: 31821886 Free article.
Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation.
Harada K, Fuji S, Seo S, Kanda J, Ueki T, Kimura F, Kato K, Uchida N, Ikegame K, Onizuka M, Matsuoka KI, Doki N, Kawakita T, Onishi Y, Yano S, Fukuda T, Takanashi M, Kanda Y, Atsuta Y, Ogata M; transplant complications working group of the Japan Society for Hematopoietic Cell Transplantation. Harada K, et al. Among authors: kawakita t. Bone Marrow Transplant. 2020 Sep;55(9):1784-1795. doi: 10.1038/s41409-020-0821-9. Epub 2020 Feb 12. Bone Marrow Transplant. 2020. PMID: 32051535
Safety and efficacy of anti-programmed cell death-1 monoclonal antibodies before and after allogeneic hematopoietic cell transplantation for relapsed or refractory Hodgkin lymphoma: a multicenter retrospective study.
Ito A, Kim SW, Matsuoka KI, Kawakita T, Tanaka T, Inamoto Y, Toubai T, Fujiwara SI, Fukaya M, Kondo T, Sugita J, Nara M, Katsuoka Y, Imai Y, Nakazawa H, Kawashima I, Sakai R, Ishii A, Onizuka M, Takemura T, Terakura S, Iida H, Nakamae M, Higuchi K, Tamura S, Yoshioka S, Togitani K, Kawano N, Suzuki R, Suzumiya J, Izutsu K, Teshima T, Fukuda T. Ito A, et al. Among authors: kawakita t. Int J Hematol. 2020 Nov;112(5):674-689. doi: 10.1007/s12185-020-02960-4. Epub 2020 Aug 3. Int J Hematol. 2020. PMID: 32748216
Comparison of immunosuppressant regimens in salvage cord blood transplantation for graft failure after allogeneic hematopoietic stem cell transplantation.
Harada K, Fuji S, Seo S, Uchida N, Kawakita T, Yano S, Ozawa Y, Yoshioka S, Onishi Y, Noguchi Y, Onizuka M, Matsuhashi Y, Kimura T, Ichinohe T, Atsuta Y; Transplant Complications Working Group of the Japan Society for Hematopoietic Cell Transplantation; GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation; Terakura S, Nakasone H. Harada K, et al. Among authors: kawakita t. Bone Marrow Transplant. 2021 Feb;56(2):400-410. doi: 10.1038/s41409-020-00999-9. Epub 2020 Aug 20. Bone Marrow Transplant. 2021. PMID: 32820226
Effect of methotrexate dose in graft-versus-host disease prophylaxis after single-unit cord blood transplantation in adult acute myeloid leukemia.
Terakura S, Kuwatsuka Y, Sugita J, Takahashi S, Ozawa Y, Ozeki K, Yoshioka S, Nakamae H, Kawakita T, Sawa M, Morishige S, Najima Y, Katsuoka Y, Sakaida E, Kouzai Y, Kimura T, Ichinohe T, Fukuda T, Atsuta Y, Murata M, Teshima T. Terakura S, et al. Among authors: kawakita t. Int J Hematol. 2021 Jun;113(6):840-850. doi: 10.1007/s12185-021-03097-8. Epub 2021 Feb 21. Int J Hematol. 2021. PMID: 33611725 Clinical Trial.
486 results